Heath Lukatch - 15 Jun 2026 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Reporting relationship: Director
Issuer ticker: PCVX
Reported as of: 15 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2026, 16:15:18 UTC
Prior SEC filing: 16 Jun 2025
Source filing: View source filing
Reporting owner signature: Heath Lukatch, by /s/ Peter N. Efremenko, Attorney-In-Fact

Key filing fact

Heath Lukatch filed Form 4 for Vaxcyte, Inc. (PCVX) on 16 Jun 2026.

Key facts

This page summarizes Heath Lukatch's Form 4 filing for Vaxcyte, Inc. (PCVX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2026, 16:15.

Change

Previous filing in this sequence was filed on 16 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001596385 Primary reporting owner

Lukatch Heath

Relationship: Director
Address: C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS
Signature: Heath Lukatch, by /s/ Peter N. Efremenko, Attorney-In-Fact
Signature date: 16 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Award

Transaction value
Shares: +2,265
Change %: +13%
Price: $0.000000^*
Shares after: 19,481
Date: 15 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCVX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +11,389
Change %
Price: $0.000000^*
Shares after: 11,389
Date: 15 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,389
Exercise price: $49.56
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Footnote F2

The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 15, 2027 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.